Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 21-Aug-2018
No. of pages: 122

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Scope of the Report:

This report focuses on the Platinum based Cancer Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Asia-Pacific is the largest sales place, with a sales market share nearly 42% in 2017. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 20%.

The worldwide market for Platinum based Cancer Drug is expected to grow at a CAGR of roughly 3.5% over the next five years, will reach 1580 million US$ in 2023, from 1290 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- Sanofi

- Hengrui Medicine

- ASK Pharma

- Yi Bai Pharmaceutical

- Qilu Pharmaceutical

- Teva

- Pfizer

- Dr Reddy's Laboratories

- Mylan

- Sun Pharma

- Novartis

- Debiopharm

- Accord Healthcare

- SK Chemicals

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Cisplatin

- Oxaliplatin

- Carboplatin

- Other

Market Segment by Applications, can be divided into

- Colorectal Cancer

- Ovarian Cancer

- Lung Cancer

- Other

There are 15 Chapters to deeply display the global Platinum based Cancer Drug market.

Chapter 1, to describe Platinum based Cancer Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Platinum based Cancer Drug, with sales, revenue, and price of Platinum based Cancer Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Platinum based Cancer Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Platinum based Cancer Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Platinum based Cancer Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Platinum based Cancer Drug Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Platinum based Cancer Drug Introduction
1.2 Market Analysis by Type
1.2.1 Cisplatin
1.2.2 Oxaliplatin
1.2.3 Carboplatin
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Colorectal Cancer
1.3.2 Ovarian Cancer
1.3.3 Lung Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Platinum based Cancer Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Hengrui Medicine
2.2.1 Business Overview
2.2.2 Platinum based Cancer Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 ASK Pharma
2.3.1 Business Overview
2.3.2 Platinum based Cancer Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Yi Bai Pharmaceutical
2.4.1 Business Overview
2.4.2 Platinum based Cancer Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Qilu Pharmaceutical
2.5.1 Business Overview
2.5.2 Platinum based Cancer Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva
2.6.1 Business Overview
2.6.2 Platinum based Cancer Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Platinum based Cancer Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dr Reddy's Laboratories
2.8.1 Business Overview
2.8.2 Platinum based Cancer Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Mylan
2.9.1 Business Overview
2.9.2 Platinum based Cancer Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sun Pharma
2.10.1 Business Overview
2.10.2 Platinum based Cancer Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Novartis
2.11.1 Business Overview
2.11.2 Platinum based Cancer Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Debiopharm
2.12.1 Business Overview
2.12.2 Platinum based Cancer Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Accord Healthcare
2.13.1 Business Overview
2.13.2 Platinum based Cancer Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 SK Chemicals
2.14.1 Business Overview
2.14.2 Platinum based Cancer Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Platinum based Cancer Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Platinum based Cancer Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Platinum based Cancer Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Platinum based Cancer Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Platinum based Cancer Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Platinum based Cancer Drug Market Analysis by Regions
4.1 Global Platinum based Cancer Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Platinum based Cancer Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Platinum based Cancer Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.3 Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.5 South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
5 North America Platinum based Cancer Drug by Countries
5.1 North America Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
5.3 Canada Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6 Europe Platinum based Cancer Drug by Countries
6.1 Europe Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.3 UK Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.4 France Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.5 Russia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
6.6 Italy Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Platinum based Cancer Drug by Countries
7.1 Asia-Pacific Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.3 Japan Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.4 Korea Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.5 India Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
8 South America Platinum based Cancer Drug by Countries
8.1 South America Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Platinum based Cancer Drug by Countries
9.1 Middle East and Africa Platinum based Cancer Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Platinum based Cancer Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Platinum based Cancer Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.3 UAE Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
10 Global Platinum based Cancer Drug Market Segment by Type
10.1 Global Platinum based Cancer Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Platinum based Cancer Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Platinum based Cancer Drug Revenue and Market Share by Type (2013-2018)
10.2 Cisplatin Sales Growth and Price
10.2.1 Global Cisplatin Sales Growth (2013-2018)
10.2.2 Global Cisplatin Price (2013-2018)
10.3 Oxaliplatin Sales Growth and Price
10.3.1 Global Oxaliplatin Sales Growth (2013-2018)
10.3.2 Global Oxaliplatin Price (2013-2018)
10.4 Carboplatin Sales Growth and Price
10.4.1 Global Carboplatin Sales Growth (2013-2018)
10.4.2 Global Carboplatin Price (2013-2018)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2013-2018)
10.5.2 Global Other Price (2013-2018)
11 Global Platinum based Cancer Drug Market Segment by Application
11.1 Global Platinum based Cancer Drug Sales Market Share by Application (2013-2018)
11.2 Colorectal Cancer Sales Growth (2013-2018)
11.3 Ovarian Cancer Sales Growth (2013-2018)
11.4 Lung Cancer Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Platinum based Cancer Drug Market Forecast (2018-2023)
12.1 Global Platinum based Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Platinum based Cancer Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.2 Europe Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.4 South America Platinum based Cancer Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Platinum based Cancer Drug Market Forecast (2018-2023)
12.3 Platinum based Cancer Drug Market Forecast by Type (2018-2023)
12.3.1 Global Platinum based Cancer Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Platinum based Cancer Drug Market Share Forecast by Type (2018-2023)
12.4 Platinum based Cancer Drug Market Forecast by Application (2018-2023)
12.4.1 Global Platinum based Cancer Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Platinum based Cancer Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Platinum based Cancer Drug Picture
Table Product Specifications of Platinum based Cancer Drug
Figure Global Sales Market Share of Platinum based Cancer Drug by Types in 2017
Table Platinum based Cancer Drug Types for Major Manufacturers
Figure Cisplatin Picture
Figure Oxaliplatin Picture
Figure Carboplatin Picture
Figure Other Picture
Figure Platinum based Cancer Drug Sales Market Share by Applications in 2017
Figure Colorectal Cancer Picture
Figure Ovarian Cancer Picture
Figure Lung Cancer Picture
Figure Other Picture
Figure United States Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Platinum based Cancer Drug Revenue (Value) and Growth Rate (2013-2023)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Platinum based Cancer Drug Type and Applications
Table Sanofi Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table Hengrui Medicine Platinum based Cancer Drug Type and Applications
Table Hengrui Medicine Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ASK Pharma Basic Information, Manufacturing Base and Competitors
Table ASK Pharma Platinum based Cancer Drug Type and Applications
Table ASK Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Yi Bai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Yi Bai Pharmaceutical Platinum based Cancer Drug Type and Applications
Table Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Platinum based Cancer Drug Type and Applications
Table Qilu Pharmaceutical Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Platinum based Cancer Drug Type and Applications
Table Teva Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Platinum based Cancer Drug Type and Applications
Table Pfizer Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table Dr Reddy's Laboratories Platinum based Cancer Drug Type and Applications
Table Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Platinum based Cancer Drug Type and Applications
Table Mylan Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Platinum based Cancer Drug Type and Applications
Table Sun Pharma Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Platinum based Cancer Drug Type and Applications
Table Novartis Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Debiopharm Basic Information, Manufacturing Base and Competitors
Table Debiopharm Platinum based Cancer Drug Type and Applications
Table Debiopharm Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table Accord Healthcare Platinum based Cancer Drug Type and Applications
Table Accord Healthcare Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table SK Chemicals Basic Information, Manufacturing Base and Competitors
Table SK Chemicals Platinum based Cancer Drug Type and Applications
Table SK Chemicals Platinum based Cancer Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Platinum based Cancer Drug Sales by Manufacturer (2016-2017)
Figure Global Platinum based Cancer Drug Sales Market Share by Manufacturer in 2016
Figure Global Platinum based Cancer Drug Sales Market Share by Manufacturer in 2017
Table Global Platinum based Cancer Drug Revenue by Manufacturer (2016-2017)
Figure Global Platinum based Cancer Drug Revenue Market Share by Manufacturer in 2016
Figure Global Platinum based Cancer Drug Revenue Market Share by Manufacturer in 2017
Figure Top 3 Platinum based Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Platinum based Cancer Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Global Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Global Platinum based Cancer Drug Sales by Regions (2013-2018)
Table Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018)
Table Global Platinum based Cancer Drug Revenue by Regions (2013-2018)
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions in 2013
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions in 2017
Figure North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure North America Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table North America Platinum based Cancer Drug Sales by Countries (2013-2018)
Table North America Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure North America Platinum based Cancer Drug Sales Market Share by Countries in 2013
Figure North America Platinum based Cancer Drug Sales Market Share by Countries in 2017
Table North America Platinum based Cancer Drug Revenue by Countries (2013-2018)
Table North America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure North America Platinum based Cancer Drug Revenue Market Share by Countries in 2013
Figure North America Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure United States Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Canada Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Mexico Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Europe Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Europe Platinum based Cancer Drug Sales by Countries (2013-2018)
Table Europe Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Table Europe Platinum based Cancer Drug Revenue by Countries (2013-2018)
Figure Europe Platinum based Cancer Drug Revenue Market Share by Countries in 2016
Figure Europe Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure Germany Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure UK Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure France Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Russia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Italy Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Platinum based Cancer Drug Sales by Countries (2013-2018)
Table Asia-Pacific Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Sales Market Share by Countries 2017
Table Asia-Pacific Platinum based Cancer Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Platinum based Cancer Drug Revenue Market Share by Countries 2017
Figure China Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Japan Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Korea Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure India Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure South America Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table South America Platinum based Cancer Drug Sales by Countries (2013-2018)
Table South America Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure South America Platinum based Cancer Drug Sales Market Share by Countries in 2017
Table South America Platinum based Cancer Drug Revenue by Countries (2013-2018)
Table South America Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure South America Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure Brazil Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Argentina Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Colombia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Platinum based Cancer Drug Sales by Countries (2013-2018)
Table Middle East and Africa Platinum based Cancer Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Platinum based Cancer Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Platinum based Cancer Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure UAE Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Egypt Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Figure South Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018)
Table Global Platinum based Cancer Drug Sales by Type (2013-2018)
Table Global Platinum based Cancer Drug Sales Share by Type (2013-2018)
Table Global Platinum based Cancer Drug Revenue by Type (2013-2018)
Table Global Platinum based Cancer Drug Revenue Share by Type (2013-2018)
Figure Global Cisplatin Sales Growth (2013-2018)
Figure Global Cisplatin Price (2013-2018)
Figure Global Oxaliplatin Sales Growth (2013-2018)
Figure Global Oxaliplatin Price (2013-2018)
Figure Global Carboplatin Sales Growth (2013-2018)
Figure Global Carboplatin Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Platinum based Cancer Drug Sales by Application (2013-2018)
Table Global Platinum based Cancer Drug Sales Share by Application (2013-2018)
Figure Global Ovarian Cancer Sales Growth (2013-2018)
Figure Global Lung Cancer Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Platinum based Cancer Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Platinum based Cancer Drug Sales Forecast by Regions (2018-2023)
Table Global Platinum based Cancer Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure Europe Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure South America Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Platinum based Cancer Drug Market Forecast (2018-2023)
Table Global Platinum based Cancer Drug Sales Forecast by Type (2018-2023)
Table Global Platinum based Cancer Drug Market Share Forecast by Type (2018-2023)
Table Global Platinum based Cancer Drug Sales Forecast by Application (2018-2023)
Table Global Platinum based Cancer Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Soft Gelatin Capsules Market Data Survey Report 2025
    Published: 10-Nov-2018        Price: US 1500 Onwards        Pages: 87
    Summary The global Soft Gelatin Capsules market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capaci......
  • Global Tissue Engineered Bone Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 113
    This report studies the global Tissue Engineered Bone market status and forecast, categorizes the global Tissue Engineered Bone market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Johnson & Johnson - Stryker - Zimmer Biomet - Medtronic......
  • Global Balsalazide Market Insights, Forecast to 2025
    Published: 09-Nov-2018        Price: US 3900 Onwards        Pages: 117
    Balsalazide is an oral anti-inflammatory drug that is used for the treatment of ulcerative colitis. In 2017, the global Balsalazide market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Balsalazide market based on company, product type, application and key regions. This report studies the global market size of Balsalazide in key regions li......
  • Global Biperiden Market Insights, Forecast to 2025
    Published: 09-Nov-2018        Price: US 3900 Onwards        Pages: 117
    This report studies the global market size of Biperiden in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Biperiden in these regions. This research report categorizes the global Biperiden market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, ......
  • Global Botulinum Neurotoxins Market Insights, Forecast to 2025
    Published: 09-Nov-2018        Price: US 3900 Onwards        Pages: 148
    This report studies the global market size of Botulinum Neurotoxins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Botulinum Neurotoxins in these regions. This research report categorizes the global Botulinum Neurotoxins market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market dri......
  • Global Human Fibrinogen Concentrate Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 111
    This report studies the global Human Fibrinogen Concentrate market status and forecast, categorizes the global Human Fibrinogen Concentrate market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - CSL Behring - LFB Group - Shanghai RAAS - Hua......
  • Global Acetohydroxamic Acid Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Nov-2018        Price: US 3480 Onwards        Pages: 119
    Acetohydroxamic acid (also known as AHA or by the trade name Lithostat) is a drug that is a potent and irreversible enzyme inhibitor of the urease enzyme in various bacteria and plants; it is usually used for urinary tract infections. Scope of the Report: The elderly population in itself is a large number for urinary tract infections and hence, a high demand for acetohydroxamic acid. The worldwide market for Acetohydroxamic Acid is expected to grow at......
  • Global Influenza Drugs Market Research Report 2018
    Published: 09-Nov-2018        Price: US 2900 Onwards        Pages: 121
    This report studies the global Influenza Drugs market status and forecast, categorizes the global Influenza Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report - Bristol-Myers Squibb] - AstraZeneca - Eli Lilly - Roche - GlaxoS......
  • Global Conjugated Estrogen Market Insights, Forecast to 2025
    Published: 09-Nov-2018        Price: US 3900 Onwards        Pages: 113
    Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares' urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Menopause is a natural and normal process in women, which occurs due to aging and lowers the function of ovaries and lowers the levels of estrogen and other hormones in the body. The growing prevalence of the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs